2022 Spring Advances in Neurology - May 13-14, 2022

The 14th annual Advances in Neurology course hosted by the University of Louisville Department Of Neurology. This year’s focus will include updates on all subspecialties in neurology from local, regional and nationally recognized experts in the field.
When May 13, 2022 08:00 AM to
May 14, 2022 02:00 PM
Where Virtual via Zoom
Contact Name
Contact Phone 502-852-3285
Add event to calendarvCal
iCal

 

Target Audience
Physicians, Nurse Practitioners, Nurses, Allied Health Professionals, Residents and Students.

Agenda
Friday, May 13, 2022        
8:00 a.m. - 9:00 a.m.
Current State of Pediatric Stroke
Arpita Lakhotia, MD

9:00 a.m. - 10:00 a.m.
Hot Topics from ISC 2022
Saurav Das, MD

10:00 a.m. - 10:15 a.m.    
Break

10:15 a.m. - 11:15 a.m.
Long-term Effects of Stroke/stroke Prevention
Kim Meyer, CNRN, APRN, PhD

11:15 a.m. - 12:15 p.m.
Stroke Hot Topics Debate    
Michael Haboubi, DO

12:15 p.m. - 12:30 p.m.    
Lunch

12:30 p.m. - 1:30 p.m.
Keynote: Secondary Stroke Prevention
Larry Goldstein, MD

1:30 p.m. - 2:30 p.m.    
Moya Moya
Saad Hasan, MD
           
Saturday, May 14            
8:00 a.m. - 8:45 a.m.
Cognitive
Gregory Cooper, MD, PhD

8:45 a.m. - 9:30 a.m.
Headache
Michael Sowell, MD

9:30 a.m. - 10:15 a.m.
Epilepsy PNES
Lahoma Prather, DNP, RN

10:15 a.m. - 10:30 a.m.
Break    

10:30 a.m. - 11:15 a.m.
Movement Disorders
Peter Hedera, MD, PhD

11:15 a.m. - 12:00 p.m.
AAN
Alex Rae-Grant

12:00 p.m. - 12:30 p.m.    
Lunch    

12:30 p.m. - 1:15 p.m.
Neuromuscular – Updates on Myasthenia Gravis
Tuan Vu, MD

1:15 p.m. - 2:00 p.m.
Neurogenetics
Dylan Brock, MD

Course Directors
 Vishwanath Sagi, MD

Assistant Professor
Assistant Clerkship Director
Department of Neurology
University of Louisville
Louisville, KY

 Michael Sowell, MD
Professor
Departments of Neurology and Pediatrics
Director, Child Neurology Residency Program
Director, Comprehensive Headache Program
University of Louisville
Louisville, KY

Participating Faculty
Dylan Brock, MD
Assistant Professor
Department of Neurology
University of Louisville

Gregory Cooper, MD, PhD
Norton Healthcare
Louisville, Kentucky

Saurav Das, MD

Assistant Professor
Department of Neurology
University of Kentucky

Larry Goldstein, MD
Professor
Department of Neurology
University of Kentucky

Michael Haboubi, DO    
Assistant Professor
Department of Neurology
University of Louisville

Peter Hedera, MD
Professor
Movement Disorders Division
Department of Neurology
University of Louisville

Saad Hasan, MD
Fellow
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA

Arpita Lakhotia, MD    
Assistant Professor
Department of Neurology
University of Louisville

Kim Meyer, PhD    
Assistant Professor in Neurological Surgery
University of Louisville

Lahoma Prather, DNP, RN
Department of Neurology
University of Louisville

Tuan Vu, MD
Professor
University of South Florida
Tampa, FL

Learning Objectives

As a result of participating in this activity, participants should be able to:
1. Utilize best practice guidelines in regards to secondary stroke prevention.
2. Utilize best practice guidelines for the acute and preventive treatment of migraine.
3. Utilize best practice guidelines for evaluation and management of memory disorders.
4. Utilize best available evidence and practice guidelines in the treatment of motor symptoms of Parkinson disease.

Continuing Education Credit
 Physician Credit
- The University of Louisville Continuing Medical Education office designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses - This program has been approved by the Kentucky Board of Nursing for 13.5 continuing education credits through University of Louisville Hospital, provider number 4-0068-12-22-1278. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Completion criteria to obtain CE's: Attend entire session and complete the evaluation.

Accreditation
 The University of Louisville School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Special Services

All individuals are encouraged to participate. To request disability arrangements, please contact  , at (502) 852-3285 at least 14 days prior to the date of this program. Continuing Medical Education and Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.


Brochure

CLICK HERE for a copy of the course brochure

The Commonwealth Neurological Society (CNS) is the state neurology society for Kentucky. We are the organized voice of neurology to our national organization, as well as the liason with the American Medical Association, Kentucky Medical Association, and other interested parties in health care.  As such, we are best positioned to advocate for the needs of patients with neurological disorders in the Commonwealth.  We have developed a vital and growing network of neurologists and associated professionals that will benefit our practices and our patients.

Registration
There is no charge for this continuing education event. Advance registration is required.

Registration for this Conference is now closed.

Acknowledgments
We thank our supporting and exhibiting companies for their participation in the 2022 Spring Advances in Neurology. A final listing of supporters and exhibitors will be available at the webinar.

Accreditation Disclosure
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.